Reports
Sale
Chile In-Vitro Diagnostics Market Size, Growth, Forecast: By Product and Services: Reagents and Kits, Instruments, Software and Services; By Test: Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Haematology, Others; By Therapeutic Area: Oncology, Infectious Diseases, Others; By End User; Competitive Landscape; 2024-2032
Chile In-Vitro Diagnostics Market Outlook
The Chile in-vitro diagnostics market size was approximately USD 799.46 million in 2023. The market is assessed to grow at a CAGR of 4.60% between 2024 and 2032, reaching a value of USD 1195.61 million by 2032.
Key Takeaways
- The in-vitro diagnostics sector is currently experiencing a revolution, driven by the emergence of next-generation sequencing, the development of biosensors, and advancements in digital health and wearable technologies.
- There is an increasing need for in-vitro diagnostics among the elderly and overweight individuals suffering from cardiovascular and metabolic issues, as well as diabetes.
- The notable trends in the market include point-of-care testing, automation and digitalisation, and the concept of personalised medicine.
As per the Chile in-vitro diagnostics market analysis, the rapid increase in the geriatric and obese population in the country has led to a higher demand for diagnostic tests. Additionally, the population's increased vulnerability to cardiovascular and metabolic disorders has further fuelled the demand for necessary tests and treatments. The prevalence of chronic diseases such as cancer has been on the rise due to unhealthy eating habits among the younger generation and adverse environmental conditions. This has created a need for more advanced diagnostic tools and procedures, which has contributed to the expansion of the in-vitro diagnostics market.
The market is greatly influenced by the enhancement of health services and facilities in the country. This factor plays a crucial role in improving healthcare outcomes for patients. The trend towards home sampling and point-of-care diagnosis, along with the availability of rapid test results, has significantly streamlined diagnostic and treatment procedures. This enables healthcare professionals to promptly determine the appropriate course of action or treatment. Moreover, the rising popularity of clinical chemistry tests for identifying diabetes and anaemia is enhancing the Chile in-vitro diagnostics market share.
Furthermore, the development of robust diagnostics facilities in Chile is essential to address the needs of the population. In 2021, there was a 12.7% prevalence of diabetes among adults, with a total of 1,747,100 cases in Chile. The country is witnessing a rise in type 2 diabetes among its adult population, prompting a focus on diagnosis and treatment through universal healthcare coverage, particularly emphasising the clinical aspects of the disease. Therefore, timely diagnosis and preventive measures are crucial in managing the disease effectively. Conventional biosensors like glucose meters and glycohemoglobin test kits are commonly utilised for in vitro testing due to their direct relevance to diabetes diagnosis and long-term care.
Market Segmentation
Chile In-Vitro Diagnostics Market Report and Forecast 2024-2032 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product and Services
- Reagents and Kits
- Instruments
- Software and Services
Market Breakup by Test
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostics
- Haematology
- Others
Market Breakup by Therapeutic Area
- Oncology
- Infectious Diseases
- Diabetes
- Cardiology
- Autoimmune Diseases
- Others
Market Breakup by End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
Competitive Landscape
In order to gain a competitive edge, the market players are increasingly focusing on incorporating advanced technologies into in-vitro diagnostics and laboratory tests.
- Abbott Laboratories
- bioMérieux SA
- F. Hoffmann-La Roche Ltd
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- WAMA Diagnóstica
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc
- Stevanato Group.
- Siemens Healthcare GmbH
- Others
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Test |
|
| Breakup by Therapeutic Area |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 Chile In-Vitro Diagnostics Market Overview
8.1 Key Industry Highlights
8.2 Chile In-Vitro Diagnostics Historical Market (2017-2023)
8.3 Chile In-Vitro Diagnostics Market Forecast (2024-2032)
9 Chile In-Vitro Diagnostics Market by Product and Services
9.1 Reagents and Kits
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Instruments
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Software and Services
9.3.1 Historical Trend (2017-2023)
9.3.2 Forecast Trend (2024-2032)
10 Chile In-Vitro Diagnostics Market by Test
10.1 Clinical Chemistry
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Molecular Diagnostics
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 Immunodiagnostics
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Haematology
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Chile In-Vitro Diagnostics Market by Therapeutic Area
11.1 Oncology
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Infectious Diseases
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 Diabetes
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 Cardiology
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Autoimmune Diseases
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Chile In-Vitro Diagnostics Market by End User
12.1 Hospitals and Clinics
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Diagnostic Laboratories
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Academic and Research Institutes
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Market Dynamics
13.1 SWOT Analysis
13.1.1 Strengths
13.1.2 Weaknesses
13.1.3 Opportunities
13.1.4 Threats
13.2 Porter’s Five Forces Analysis
13.2.1 Supplier’s Power
13.2.2 Buyer’s Power
13.2.3 Threat of New Entrants
13.2.4 Degree of Rivalry
13.2.5 Threat of Substitutes
13.3 Key Indicators for Demand
13.4 Key Indicators for Price
14 Competitive Landscape
14.1 Market Structure
14.2 Company Profiles
14.2.1 Abbott Laboratories
14.2.1.1 Company Overview
14.2.1.2 Product Portfolio
14.2.1.3 Demographic Reach and Achievements
14.2.1.4 Certifications
14.2.2 bioMérieux SA
14.2.2.1 Company Overview
14.2.2.2 Product Portfolio
14.2.2.3 Demographic Reach and Achievements
14.2.2.4 Certifications
14.2.3 F. Hoffmann-La Roche Ltd
14.2.3.1 Company Overview
14.2.3.2 Product Portfolio
14.2.3.3 Demographic Reach and Achievements
14.2.3.4 Certifications
14.2.4 Sysmex Corporation
14.2.4.1 Company Overview
14.2.4.2 Product Portfolio
14.2.4.3 Demographic Reach and Achievements
14.2.4.4 Certifications
14.2.5 Thermo Fisher Scientific Inc.
14.2.5.1 Company Overview
14.2.5.2 Product Portfolio
14.2.5.3 Demographic Reach and Achievements
14.2.5.4 Certifications
14.2.6 WAMA Diagnóstica
14.2.6.1 Company Overview
14.2.6.2 Product Portfolio
14.2.6.3 Demographic Reach and Achievements
14.2.6.4 Certifications
14.2.7 Becton, Dickinson and Company
14.2.7.1 Company Overview
14.2.7.2 Product Portfolio
14.2.7.3 Demographic Reach and Achievements
14.2.7.4 Certifications
14.2.8 Bio-Rad Laboratories, Inc
14.2.8.1 Company Overview
14.2.8.2 Product Portfolio
14.2.8.3 Demographic Reach and Achievements
14.2.8.4 Certifications
14.2.9 Stevanato Group.
14.2.9.1 Company Overview
14.2.9.2 Product Portfolio
14.2.9.3 Demographic Reach and Achievements
14.2.9.4 Certifications
14.2.10 Siemens Healthcare GmbH
14.2.10.1 Company Overview
14.2.10.2 Product Portfolio
14.2.10.3 Demographic Reach and Achievements
14.2.10.4 Certifications
14.2.11 Others
15 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Chile In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2032
2. Chile In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2023
3. Chile In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Chile In-Vitro Diagnostics Historical Market: Breakup by Test (USD Million), 2017-2023
5. Chile In-Vitro Diagnostics Market Forecast: Breakup by Test (USD Million), 2024-2032
6. Chile In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2023
7. Chile In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Chile In-Vitro Diagnostics Historical Market: Breakup by End User (USD Million), 2017-2023
9. Chile In-Vitro Diagnostics Market Forecast: Breakup by End User (USD Million), 2024-2032
10. Chile In-Vitro Diagnostics Market Structure
Key Questions Answered in the Report
In 2023, the market reached an approximate value of USD 799.46 million.
The market is estimated to grow at a CAGR of 4.60% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach a value of around USD 1195.61 million by 2032.
The rise in chronic diseases, the introduction of innovative diagnostic tools, and the rapid growth of the elderly and obese population in Chile are the primary drivers behind the expansion of the in-vitro diagnostics market.
The improvement in healthcare services and the increasing popularity of private and home-based sampling methods are the key trends shaping the growth of the in-vitro diagnostic market in Chile.
The major products and services offered in the market are reagents and kits, instruments, and software and services.
The major end users in the market are hospitals and clinics, diagnostic laboratories, and academic and research institutes, among others.
The major players in the market are Abbott Laboratories, bioMérieux SA, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., WAMA Diagnóstica, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, Stevanato Group., and Siemens Healthcare GmbH, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER